Menu
  • Home
  • About Us
    • About 340B Report
    • Who We Are
    • Testimonials
    • Work With 340B Report
    • Contact
  • Subscribe Now
  • Document Center
  • Expert Directory
  • Events Calendar
  • Industry Insights
  • Sponsor/Advertise
  • Sign in
340B Report

340B Report

Category: Breaking

BREAKING: Bipartisan Group of 217 U.S. Representatives Ask HHS to Stop 340B Rebate Model and Look Into Third Party Vendors

In Breaking, Federal, Legislative, Other Industry, Pharma Industry, RegulatoryNovember 13, 2020 Tom Mirga
…
Read More »

BREAKING: Novartis Retreats, But Not Entirely, on 340B Contract Pharmacy (Update 2)

In Breaking, Federal, Pharma Industry, RegulatoryOctober 30, 2020 Tom Mirga

Novartis Retreats, But Not Entirely, on 340B Contract Pharmacy (Update 2)

Update 2, Friday Oct. 30, 4:00 p.m. EDT—Hospital group 340B Health said Novartis’ action was inexcusable. “The

…
Read More »

BREAKING: Health Centers Sue HHS Over Drug Company Denials of 340B Pricing

In Breaking, Federal, Judicial, Pharma Industry, Regulatory, Trade AssociationOctober 21, 2020 Tom Mirga

Health Centers Sue HHS Over Drug

…
Read More »

BREAKING: Major Developments in 340B Hospital Lawsuit and in 340B Contract Pharmacy Dispute

In Breaking, Federal, Judicial, Regulatory, UncategorizedOctober 16, 2020 Tom Mirga

U.S. Appeals Court Won’t Rehear Lawsuit

…
Read More »

BREAKING: HIV/AIDS Clinics Sue HHS Over Drug Manufacturers’ Denials of 340B Pricing

In Breaking, Federal, Judicial, Pharma Industry, Regulatory, Trade AssociationOctober 10, 2020 Tom Mirga

HIV/AIDS Clinics Sue HHS Over Drug

…
Read More »

BREAKING: Congressional GOP Committee Leaders Seek 340B Reform Ideas by Oct. 30

In Breaking, Federal, LegislativeOctober 9, 2020 Tom Mirga

340B program changes “are needed and
…
Read More »

BREAKING: Connecticut Attorney General Demands Five Manufacturers Cease 340B Actions

In Breaking, Federal, Pharma Industry, Regulatory, StateOctober 6, 2020 Tom Mirga
SPONSORED BY


A

…
Read More »

BREAKING: Novartis Says It’s Weighing Whether to Start Cutting Off 340B Contract Pharmacy Discounts on Oct. 1. Sanofi Says it Will. (Update 1)

In Breaking, Federal, Pharma Industry, RegulatorySeptember 25, 2020 Tom Mirga
SPONSORED BY


…

Read More »

BREAKING: HHS Top Lawyer Tells Lilly, Don’t Assume We Endorse Your 340B Policy

In Breaking, Federal, Pharma Industry, RegulatorySeptember 23, 2020 Tom Mirga
SPONSORED BY


…

Read More »

BREAKING: Rule Implementing 340B Executive Order on Insulin Might be Imminent

In Breaking, Federal, RegulatorySeptember 21, 2020 Tom Mirga
SPONSORED BY


…

Read More »

Posts navigation

1 2 3 4 5

Site Sidebar

Categories

  • Breaking
  • Federal
  • Judicial
  • Legislative
  • Non-Governmental
  • Other Industry
  • Pharma Industry
  • Regulatory
  • Research/Reports
  • State
  • Trade Association
  • Uncategorized

Recent Posts

  • Our First Issue Behind Our Paywall
  • Gilead Adjusts Planned Change in its Patient Assistance After HIV Community Pushes Back
  • HHS Asks Court to Toss Out Hospitals’ 340B Contract Pharmacy Lawsuit
  • View From Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program
  • Senate Finance Report Might Shed Light on Insulin Manufacturers’ 340B Contract Pharmacy Actions

Site Footer

Terms of Use Privacy Policy